MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SINHA, B. K.
Right arrow Articles by Cox, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SINHA, B. K.
Right arrow Articles by Cox, M. G.

Molecular Pharmacology, Vol 17, 432-434, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Stimulation of Superoxide Formation by Actinomycin D and Its N2-Substituted Spin-Labeled Derivatives

BIRANDRA K. SINHA 1 and MICHAEL G. Cox 1

1 Laboratory of Environmental Biophysics, National Institute of Environmental Health Sciences, Post Office Box 12233, Research Triangle Park, North Carolina 27709

The mechanism of action of actinomycin D (AMD) is related to its interactions with DNA and inhibition of RNA synthesis. Recently, it has been shown that AMD stimulates the formation of superoxide when incubated with microsomal proteins. We have prepared N2-[4-(2,2,6,6-tetramethyl-1-piperidinyloxyl)]actinomycin D and the related 1,3-diaminopropane analogs, which were found to be more active than AMD in vivo against P-388 leukemia cells in spite of their poor DNA binding properties. We have investigated the stimulation of superoxide formation by these compounds as a possible mechanism of action. These analogs are more effective in stimulating O2 uptake and the formation of O2- than the parent AMD. The better antitumor activities of these analogs may be related to the increased O2 formation in vivo.

Note:
ACKNOWLEDGMENTS The authors wish to thank Drs. C. F. Chignell and R. P. Mason for their helpful discussions during the preparation of the manuscript.

Submitted on September 17, 1979
Accepted on November 17, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics